Session 5: COGs control - how far do we still have to go, and what should be our key targets for further progress in reducing manufacturing and supply chain costs?
20 Jan 2027
Theatre 4
Commercializing Advanced Therapies
Chairperson
Topic
CDMO CRO & Partnering,Commercialisation & Market Access,Manufacturing CMC & Supply Chain
Persona
Biotech,CMC & Supply Chain,Pharma,Service Providers (CDMOs CROs & Suppliers)